Hexarelin 2mg

12.00

Availability: Available on back-order SKU: HEXA-2mg Category: Tags: ,

Hexarelin 2mg

12.00

In stock

Description

Hexarelin is a synthetic hexapeptide belonging to the class of growth hormone releasing peptides (GHRPs). It is studied in laboratory environments for its role in growth hormone (GH) secretion, ghrelin receptor activation, and endocrine signalling pathways.

In controlled research settings, Hexarelin acts as a growth hormone secretagogue receptor (GHS-R) agonist, stimulating the release of growth hormone from the pituitary gland. It is often investigated for its potent GH-releasing activity compared to other peptides within the same class.

Across Ireland and Europe, Hexarelin is commonly used in research areas such as:

  • Growth hormone secretion and regulation
  • Ghrelin receptor (GHS-R) activation
  • Endocrine and neuroendocrine pathway studies
  • Hormonal signalling and metabolic research

This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.

Disclaimer: This product is strictly for research purposes only and is not for human consumption.

Technical Information – Hexarelin

Specification Details
Product Name Hexarelin
Compound Type Synthetic hexapeptide
Functional Class Growth hormone releasing peptide (GHRP)
Mechanism of Action Ghrelin receptor (GHS-R) agonist
Biological Targets Pituitary gland, GHS-R receptors
Amino Acid Length 6 amino acids
Format Lyophilised powder
Purity Research-grade (high purity)
Storage Refrigerated (2–8°C, protected from light)
Application Laboratory research use only

* Images for illustration purposes only

Further Refrences: PubChem Entry

Researched Benefits & Focus Areas – Hexarelin

1. Growth Hormone (GH) Secretion Research

Hexarelin has been studied for:

  • Strong stimulation of endogenous GH release
  • Investigation of pituitary gland signalling pathways
  • Analysis of hormonal secretion dynamics

Reference basis: Derived from endocrinology and pharmacology studies examining growth hormone releasing peptides and pituitary activation.


2. Ghrelin Receptor (GHS-R) Activation

Research has explored:

  • Binding to growth hormone secretagogue receptors
  • Influence on ghrelin signalling pathways
  • Role in hormonal and metabolic regulation research

Reference basis: Based on biochemical studies investigating ghrelin receptor agonists and peptide-receptor interactions.


3. Cardiovascular & Cellular Signalling Research

Hexarelin has been investigated for:

  • Interaction with cardiac and vascular signalling pathways (research models)
  • Potential role in cellular protection mechanisms
  • Influence on tissue signalling under stress conditions

Reference basis: Supported by preclinical research examining Hexarelin’s interaction with cardiovascular and cellular signalling systems.


4. Endocrine System Modulation

  • Studied for its role in hormonal balance and signalling
  • Explored in GH/IGF-1 axis research
  • Investigated within neuroendocrine system models

Reference basis: Derived from clinical and experimental research into endocrine system regulation and peptide signalling.


Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.

Researched Risks & Considerations – Hexarelin

1. Hormonal System Impact

  • May significantly influence growth hormone levels
  • Potential for endocrine imbalance in research models

Reference basis: Based on studies examining GH regulation and hormonal feedback systems.


2. Receptor Desensitisation

  • Continuous stimulation may lead to reduced receptor responsiveness
  • Potential for diminished effect over time in models

Reference basis: Derived from research into receptor desensitisation and peptide signalling dynamics.


3. Off-Target Biological Effects

  • Possible interaction with non-target receptors
  • Broad systemic influence across biological signalling pathways

Reference basis: Based on studies examining peptide distribution and multi-system interactions.


4. Limited Long-Term Research

  • Lack of extensive long-term data
  • Primarily studied in controlled laboratory environments

Reference basis: Reflects the current stage of growth hormone releasing peptide research.


Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.

Additional information

Weight 23 kg
Dimensions 12 × 23 × 56 cm
Quantity

1 Vial, 1 Kit (10 Vials)

Related Products

FEATURED PRODUCTS

BEST SELLING PRODUCTS

LATEST PRODUCTS

Retatrutide 10mg

100.00

Vilon 20mg

35.00

Vesugen 20mg

35.00

TOP RATED PRODUCTS

Acetic Acid 10ml

11.99

Retatrutide 10mg

100.00

Vilon 20mg

35.00